Published by Iain Gilbert on 24th June 2021
(Sharecast News) - Commercial biotechnology company Allergy Therapeutics said on Thursday that full-year operating profits were expected to be "well ahead" of market expectations thanks to "significantly lower" expenses.
URL: http://www.digitallook.com/dl/news/story/31941684/...